{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:20Z","timestamp":1792791560180,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA017447"],"award-info":[{"award-number":["AA017447"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA014351"],"award-info":[{"award-number":["AA014351"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111187","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:45:12Z","timestamp":1789119912000},"page":"111187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats"],"prefix":"10.1016","volume":"301","author":[{"given":"Laura","family":"Rullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana Maria","family":"Losapio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hela","family":"Mrizak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Morosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Nasuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Ubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4680-2310","authenticated-orcid":false,"given":"Paolo","family":"Mangione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3085-8365","authenticated-orcid":false,"given":"Antonio","family":"Lacorte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia","family":"Coluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soverchia","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-8679","authenticated-orcid":false,"given":"Nazzareno","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8905-7393","authenticated-orcid":false,"given":"Sanzio","family":"Candeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ciccocioppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Romualdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111187_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1369-1600.2012.00466.x","article-title":"Modification of anxiety-like behaviors by nociceptin\/orphanin FQ (N\/OFQ) and time-dependent changes in N\/OFQ-NOP gene expression following ethanol withdrawal","volume":"18","author":"Aujla","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/0269881115581962","article-title":"Intimate insight: MDMA changes how people talk about significant others","volume":"29","author":"Baggott","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1099-1077(200010)15:7<559::AID-HUP230>3.0.CO;2-J","article-title":"Hallucinogenic drugs attenuate the subjective response to alcohol in humans","volume":"15","author":"Barrett","year":"2000","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pbb.2008.02.018","article-title":"Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain","volume":"90","author":"Baumann","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111187_bib5","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1007\/s12035-017-0844-4","article-title":"Dynorphin and \u03ba-Opioid receptor dysregulation in the dopaminergic reward system of human alcoholics","volume":"55","author":"Bazov","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-023-06384-w","article-title":"Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories","volume":"240","author":"Benvenuti","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111187_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/026988110201600112","article-title":"Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat","volume":"16","author":"Blokland","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib8","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41380-020-0690-z","article-title":"Kappa opioid receptor and dynorphin signaling in the central amygdala regulates alcohol intake","volume":"26","author":"Bloodgood","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111187_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108874","article-title":"Central nucleus of the amygdala projections onto the nucleus accumbens core regulate binge-like alcohol drinking in a CRF-dependent manner","volume":"203","author":"Borrego","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/bph.14915","article-title":"NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area","volume":"177","author":"Borruto","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41386-021-01096-1","article-title":"NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats","volume":"46","author":"Borruto","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108446","article-title":"Genetically selected alcohol-preferring msP rats to study alcohol use disorder: anything lost in translation?","volume":"186","author":"Borruto","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108446","article-title":"Genetically selected alcohol-preferring msP rats to study alcohol use disorder: anything lost in translation?","volume":"186","author":"Borruto","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114255","article-title":"The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms","volume":"182","author":"Caputi","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.phrs.2016.10.023","article-title":"Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure","volume":"114","author":"Caputi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.111187_bib16","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/ijms22052448","article-title":"Dysregulation of nociceptin\/orphanin FQ and dynorphin systems in the extended amygdala of alcohol preferring marchigian Sardinian (msP) rats","volume":"22","author":"Caputi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111187_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2013.12.015","article-title":"The effects of acutely administered 3,4-Methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity","volume":"78","author":"Carhart-Harris","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111187_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/brainsci14030294","article-title":"A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder","volume":"14","author":"Celik","year":"2024","journal-title":"Brain Sciences"},{"key":"10.1016\/j.neuropharm.2026.111187_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nprot.2006.83","article-title":"The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on","volume":"1","author":"Chomczynski","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2026.111187_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(99)00239-3","article-title":"Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats","volume":"373","author":"Ciccocioppo","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1369-1600.2006.00032.x","article-title":"Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism","volume":"11","author":"Ciccocioppo","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(94)00322-A","article-title":"Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats","volume":"51","author":"Ciccocioppo","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111187_bib23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00213-014-3743-7","article-title":"Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats","volume":"232","author":"Cippitelli","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111187_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00213-014-3743-7","article-title":"Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats","volume":"232","author":"Cippitelli","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111187_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1369-1600.2011.00326.x","article-title":"Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain","volume":"18","author":"D'Addario","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuroscience.2005.09.015","article-title":"Chronic and acute effects of 3,4-methylenedioxy-N-methylamphetamine ('Ecstasy\u2019) administration on the dynorphinergic system in the rat brain","volume":"137","author":"Di Benedetto","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111187_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/alcalc\/agaa139","article-title":"Targeting the opioid receptors: a promising therapeutic avenue for treatment in \u201cHeavy Drinking Smokers.\u201d","volume":"56","author":"Domi","year":"2021","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2026.111187_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2026.112802","article-title":"Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: a systematic review and meta-analysis of clinical and functional outcomes","volume":"107","author":"Fares-Otero","year":"2026","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1530-0277.2007.00379.x","article-title":"Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41)","volume":"31","author":"Finn","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2026.111187_bib30","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1038\/s41598-024-56500-9","article-title":"LY2444296, a \u03ba-opioid receptor antagonist, selectively reduces alcohol drinking in male and female Wistar rats with a history of alcohol dependence","volume":"14","author":"Flores-Ramirez","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111187_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41380-019-0449-6","article-title":"Genome-wide methylation in alcohol use disorder subjects: implications for an epigenetic regulation of the cortico-limbic glucocorticoid receptors (NR3C1)","volume":"26","author":"Gatta","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111187_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.biopsych.2014.09.008","article-title":"The central amygdala as an integrative hub for anxiety and alcohol use disorders","volume":"77","author":"Gilpin","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111187_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111187_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1176\/appi.psychotherapy.20200055","article-title":"Systematized review of psychotherapeutic components of psilocybin-assisted psychotherapy","volume":"74","author":"Horton","year":"2021","journal-title":"Am. J. Psychother."},{"key":"10.1016\/j.neuropharm.2026.111187_bib35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/scan\/nst161","article-title":"MDMA enhances emotional empathy and prosocial behavior","volume":"9","author":"Hysek","year":"2014","journal-title":"Soc. Cognit. Affect Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111187_bib36","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1093\/brain\/awae136","article-title":"Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats","volume":"147","author":"Jeanblanc","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.111187_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","article-title":"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals","volume":"57","author":"Kamilar-Britt","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111187_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/jpet.112.202903","article-title":"\u03ba-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites","volume":"346","author":"Kang-Park","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111187_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146742","article-title":"Dynorphin and its role in alcohol use disorder","volume":"1735","author":"Karkhanis","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111187_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.ALC.0000057122.36127.C2","article-title":"Alcoholism: allostasis and beyond","volume":"27","author":"Koob","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2026.111187_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib42","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0741-8329(00)00118-X","article-title":"Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain","volume":"22","author":"Lindholm","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2026.111187_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/164_2017_79","article-title":"Advances in pharmacotherapy development: human clinical studies","volume":"248","author":"Litten","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109764","article-title":"Sex-dependent effect of inflammatory pain on negative affective states is prevented by kappa opioid receptors blockade in the nucleus accumbens shell","volume":"242","author":"Lorente","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.neuron.2011.01.017","article-title":"Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling","volume":"69","author":"L\u00fcscher","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111187_bib47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1586\/14737159.1.1.92","article-title":"Mutation detection using fluorescent hybridization probes and melting curve analysis","volume":"1","author":"Lyon","year":"2001","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.neuropharm.2026.111187_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature19318","article-title":"Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala","volume":"537","author":"Marcinkiewcz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111187_bib49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","article-title":"Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse","volume":"45","author":"Meinhardt","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib50","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.111187_bib51","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.111187_bib52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111187_bib53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2017.01.005","article-title":"Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype","volume":"82","author":"Natividad","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111187_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2009.09.004","article-title":"Swim stress enhances nociceptin\/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor","volume":"58","author":"Nazzaro","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.neuint.2009.01.004","article-title":"Inhibition of serotonin outflow by nociceptin\/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: role of corticotropin releasing factor","volume":"54","author":"Nazzaro","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111187_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109356","article-title":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","volume":"233","author":"Nicholas","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111187_bib57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1176\/appi.ajp.20230887","article-title":"Multidimensional personality changes following psilocybin-assisted therapy in patients with alcohol use disorder: results from a double-blind, placebo-controlled clinical trial","volume":"182","author":"Pagni","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111187_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.alcohol.2017.01.001","article-title":"Epigenetic mechanisms of alcoholism and stress-related disorders","volume":"60","author":"Palmisano","year":"2017","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2026.111187_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/SAR.S296526","article-title":"Antisocial personality disorder among patients in treatment for alcohol use disorder (AUD): characteristics and predictors of early relapse or drop-out","volume":"12","author":"Pandey","year":"2021","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.neuropharm.2026.111187_bib60","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(03)00226-8","article-title":"Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene","volume":"24","author":"Pandey","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111187_bib61","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0091-3057(93)90212-C","article-title":"5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats","volume":"46","author":"Panocka","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111187_bib62","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00213-022-06086-9","article-title":"MDMA and memory, addiction, and depression: dose-effect analysis","volume":"239","author":"Pantoni","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111187_bib63","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2013"},{"key":"10.1016\/j.neuropharm.2026.111187_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0361-9230(00)00328-2","article-title":"Basal levels and alcohol-induced changes in nociceptin\/orphanin FQ, dynorphin, and enkephalin levels in C57BL\/6J mice","volume":"53","author":"Ploj","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111187_bib65","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.neuron.2022.09.024","article-title":"Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal","volume":"110","author":"Pomrenze","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111187_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0091-3057(92)90645-V","article-title":"Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats","volume":"43","author":"Rezvani","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111187_bib67","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a039339","article-title":"The role of the central amygdala in alcohol dependence","volume":"11","author":"Roberto","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2026.111187_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1270195","article-title":"Outcomes of early social experiences on glucocorticoid and endocannabinoid systems in the prefrontal cortex of male and female adolescent rats","volume":"17","author":"Rullo","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111187_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110540","article-title":"Prolonged nicotine exposure, via electronic cigarette, selectively increases Bdnf\/TrkB transcription, dynorphin peptide levels and OLIG2 in male rat VTA","volume":"278","author":"Rullo","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuron.2012.09.026","article-title":"Stress-related neuropeptides and addictive behaviors: beyond the usual suspects","volume":"76","author":"Schank","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111187_bib71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.004","article-title":"MDMA and PTSD treatment: \u201cPTSD: from novel pathophysiology to innovative therapeutics.\u201d","volume":"649","author":"Sessa","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111187_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuropharm.2017.11.004","article-title":"Why MDMA therapy for alcohol use disorder? And why now?","volume":"142","author":"Sessa","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111187_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fpsyt.2019.00138","article-title":"A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy","volume":"10","author":"Sessa","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111187_bib74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0269881121991792","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","volume":"35","author":"Sessa","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.991753","article-title":"A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy","volume":"13","author":"Sottile","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111187_bib76","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/adb.12573","article-title":"Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake","volume":"23","author":"Stopponi","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib77","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopsych.2010.12.010","article-title":"Activation of nuclear PPAR\u03b3 receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking","volume":"69","author":"Stopponi","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111187_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agaf031","article-title":"MDMA-assisted psychotherapy for AUD: bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up","volume":"60","author":"Thurgur","year":"2025","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2026.111187_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2016.01.053","article-title":"CaMKII\u03b1 knockdown decreases anxiety in the open field and low serotonin-induced upregulation of GluA1 in the basolateral amygdala","volume":"303","author":"Tran","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111187_bib80","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s12640-021-00416-z","article-title":"Hard boiled: alcohol use as a risk factor for MDMA-induced hyperthermia: a systematic review","volume":"39","author":"van Amsterdam","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2026.111187_bib81","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111187_bib82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1369-1600.2010.00226.x","article-title":"Systemic \u03ba-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats","volume":"16","author":"Walker","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.111187_bib83","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/scan\/nsu035","article-title":"\u201cEcstasy\u201d as a social drug: MDMA preferentially affects responses to emotional stimuli with social content","volume":"9","author":"Wardle","year":"2014","journal-title":"Soc. Cognit. Affect Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111187_bib84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2018.04.005","article-title":"Prenatal ethanol induces an anxiety phenotype and alters expression of dynorphin & nociceptin\/orphanin FQ genes","volume":"85","author":"Wille-Bille","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111187_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.111187_bib86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2013.10.011","article-title":"The biology of nociceptin\/orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence","volume":"141","author":"Witkin","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111187_bib87","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2013.08.071","article-title":"Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats","volume":"554","author":"Zhou","year":"2013","journal-title":"Neurosci. Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082600362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082600362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:38Z","timestamp":1792788998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082600362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":87,"alternative-id":["S002839082600362X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111187","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111187"}}